• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Innovation Zed wins CE mark for insulin pen add-on device

February 22, 2023 By Sean Whooley

Innovation Zed InsulCheck Dose
The InsulCheck Dose device. [Image courtesy of Innovation Zed]
Innovation Zed announced that it received CE mark approval in Europe for its InsulCheck Dose add-on device.

Dublin, Ireland-based Innovation Zed designed the InsulCheck Dose device as a single-unit add-on device for pen injectors. It automatically captures dose value dialed, injection event time stamps and temperature. The device also captures mounting and unmounting events.

According to a news release, the system logs real-time injection event data and sends it to a compatible display device. Innovation Zed said it also features compatibility with all pen injectors. The device has no buttons, calibration requirements or interference with the normal injection process. It also increases user engagement through high-quality usability support features from a vibrant OLED screen.

Innovation Zed said the regulatory nod “opens the door for commercial expansion” across the continent as the company grows. The company expects to begin a commercial launch of InsulCheck Dose in Europe this year. It also intends to introduce bespoke variations of the system to new injection devices for various drug therapies. Such expansions could come in the next few years.

“InsulCheck Dose is a third-generation product of the InsulCheck family and the most intelligent and compatible evolution of the InsulCheck platform,” said Innovation Zed CEO Dr. Dean Minnock. “InsulCheck Dose provides data that, when applied correctly, facilitates an evidence-driven approach to precision insulin management and significantly helps people with diabetes make more informed choices for their personal therapy plan.

“Our InsulCheck Dose supports all insulin pens without changing the usability of the pen in any way and without interfering in the normal injection process. In securing the CE mark for InsulCheck Dose we reached an incredible milestone for our company and for people living with diabetes in Europe.”

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Regulatory/Compliance, Technology Tagged With: Innovation Zed

IN CASE YOU MISSED IT

  • Abbott could pave new roads in diabetes management with dual sensor on the horizon
  • Tandem Diabetes Care pairs t:slim X2 pump with Abbott FreeStyle Libre 3 Plus in U.S.
  • Ypsomed, CamDiab to integrate Abbott dual glucose-ketone sensor into automated insulin delivery system
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS